Leukoencephalopathy following stereotactic radiosurgery for breast cancer brain metastases: a single-center analysis of 1,077 lesions - Summary - MDSpire
Advertisement
Leukoencephalopathy following stereotactic radiosurgery for breast cancer brain metastases: a single-center analysis of 1,077 lesions
To assess the clinical and radiological outcomes of leukoencephalopathy following stereotactic radiosurgery (SRS) in patients with brain metastases from breast cancer, highlighting its significance in treatment planning.
Key Findings:
Leukoencephalopathy is a significant delayed adverse effect following SRS, impacting cognitive functions, which necessitates careful monitoring.
The study provides the largest analysis of leukoencephalopathy in breast cancer brain metastases post-SRS, emphasizing the need for awareness among clinicians.
Statistical analysis identified risk factors for high-grade leukoencephalopathy, which could inform future treatment strategies.
Interpretation:
The findings highlight the prevalence and severity of leukoencephalopathy in patients treated with SRS for breast cancer brain metastases, emphasizing the need for careful monitoring and potential interventions.
Limitations:
Retrospective design may introduce selection bias, potentially affecting the reliability of the findings.
Exclusion of patients without follow-up MRI or clinical evaluations may limit generalizability, suggesting a need for further studies.
Conclusion:
SRS is associated with a notable risk of leukoencephalopathy in breast cancer patients, necessitating ongoing research to mitigate cognitive decline and improve patient outcomes.
